ALTANA AG Completes Sale Of Pharmaceuticals Business To Nycomed

BAD HOMBURG, Germany--(BUSINESS WIRE)--ALTANA AG (NYSE:AAA)(FWB:ALT)(GER:ALT) has successfully completed the sale of ALTANA Pharma AG and its entire pharmaceuticals business to the Danish Nycomed on December 29, 2006. The preliminary total purchase price amounts to approximately €4.6 billion. The transfer of ownership becomes effective on conclusion of December 31, 2006.

The divestment of the pharmaceuticals activities ends the Group’s involvement in two areas of business. After closing of the transaction ALTANA AG will focus on its specialty chemicals business.

ALTANA AG announced the sale of ALTANA Pharma AG and its entire pharmaceuticals business to Nycomed on September 21, 2006. Following approval by the European and U.S. antitrust authorities, the shareholders of ALTANA AG also approved the sale at the Extraordinary General Meeting held on December 19.

This press release is also available on the Internet at www.altana.com. Contacts

ALTANA AG Dr. Thomas Gauly Head of Corporate Communications & Investor Relationsr Media Relations: P + 49 (0) 6172 1712-160 P + 49 (0) 6172 1712-150 F + 49 (0) 6172 1712-158 pr@altana.de Investor Relations: P + 49 (0) 6172 1712-163 P + 49 (0) 6172 1712-165 F + 49 (0) 6172 1712-158 or Investor Relations USA: P +1 212 974 98 00 F +1 212 974 61 90 www.altana.com